After Synchron was given the go-ahead by the American Food and Drug Administration last year, the first patient from the United States was treated at Mount Sinai Hospital in New York in July 2022. This is synchron switch, the brain computer interface.
The New York-based Synchron is being backed by billionaires Bill Gates and Jeff Bezos as a rival to Elon Musk's Neuralink.
Tom Oxley and Nick Opie, two Australian professors who founded the business, announced on December 16 that their $...